Johnson & Johnson Reports Q1 2026 Results, Raises Outlook, and Increases Dividend
Summary
Johnson & Johnson reported Q1 2026 sales growth of 9.9% to $24.1 Billion and adjusted EPS of $2.70 (via Ex. 99.1). The company raised its 2026 guidance, now estimating reported sales of $100.8 Billion and adjusted EPS of $11.55 at the midpoint. Additionally, the Board declared a 3.1% increase in the quarterly dividend, from $1.30 to $1.34 per share, marking the 64th consecutive year of increases (via Ex. 99.3).
Why It Matters
The raised 2026 guidance for sales and adjusted EPS signals positive future performance. The 64th consecutive dividend increase, from $1.30 to $1.34 per share, highlights the company's commitment to shareholder returns and financial stability.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how JNJ traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View JNJ Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000200406
- Filing Date
- Tuesday, April 14, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- positive